Form 4: Haemonetics EVP, Chief Technology Officer Anila Lingamneni Reports Stock Disposals for Tax Obligations

Anila Lingamneni, EVP and Chief Technology Officer of Haemonetics Corp, reports disposals of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Anila Lingamneni, the EVP and Chief Technology Officer of Haemonetics Corp, filed a Form 4 detailing changes in beneficial ownership.
• The report indicates the disposal of common stock on May 15, 2024, and May 16, 2024, to satisfy tax obligations related to vesting restricted stock units (RSUs).
• On May 15, 2024, 337 shares were disposed of at a price of $96.49.
• On May 16, 2024, 318 shares were disposed of at a price of $94.8.
• Following these transactions, Ms. Lingamneni beneficially owns 11,640 shares of common stock, including unvested RSUs.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions for tax purposes and doesn't suggest any significant positive or negative outlook.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. Disposals to cover tax obligations are common and don't necessarily indicate a negative outlook on the company.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are related to tax obligations and do not represent a significant change in ownership.

Key Dates